MicroPort Scientific
Market Cap
HK$104.4b
Last Updated
2021/01/23 10:14 UTC
Data Sources
Company Financials +
Executive Summary
MicroPort Scientific Corporation, an investment holding company, manufactures and markets medical devices in the People’s Republic of China, North America, Europe, other Asian countries, South America, and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
High growth potential with mediocre balance sheet.
Similar Companies
Share Price & News
How has MicroPort Scientific's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 853 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: 853's weekly volatility (10%) has been stable over the past year.
Market Performance
7 Day Return
15.4%
853
10.9%
HK Medical Equipment
3.5%
HK Market
1 Year Return
551.3%
853
113.9%
HK Medical Equipment
15.1%
HK Market
Return vs Industry: 853 exceeded the Hong Kong Medical Equipment industry which returned 113.7% over the past year.
Return vs Market: 853 exceeded the Hong Kong Market which returned 17.5% over the past year.
Shareholder returns
| 853 | Industry | Market | |
|---|---|---|---|
| 7 Day | 15.4% | 10.9% | 3.5% |
| 30 Day | 42.8% | 12.5% | 12.7% |
| 90 Day | 98.1% | 20.7% | 18.1% |
| 1 Year | 552.6%551.3% | 117.3%113.9% | 19.7%15.1% |
| 3 Year | 607.3%600.4% | 223.3%207.7% | -5.1%-15.1% |
| 5 Year | 1,520.5%1,499.7% | 353.3%314.9% | 65.1%37.0% |
Long-Term Price Volatility Vs. Market
How volatile is MicroPort Scientific's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
What Kind Of Investors Own Most Of MicroPort Scientific Corporation (HKG:853)?2 months ago | Simply Wall St
What Did MicroPort Scientific's (HKG:853) CEO Take Home Last Year?3 months ago | Simply Wall St
Does MicroPort Scientific (HKG:853) Have A Healthy Balance Sheet?Valuation
Is MicroPort Scientific undervalued compared to its fair value and its price relative to the market?
20.19x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 853 (HK$58.55) is trading above our estimate of fair value (HK$22.92)
Significantly Below Fair Value: 853 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 853 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.
PE vs Market: 853 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 853's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 853 is overvalued based on its PB Ratio (20.2x) compared to the HK Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is MicroPort Scientific forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
47.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 853 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: 853 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 853's is expected to become profitable in the next 3 years.
Revenue vs Market: 853's revenue (23.1% per year) is forecast to grow faster than the Hong Kong market (14.4% per year).
High Growth Revenue: 853's revenue (23.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 853's Return on Equity is forecast to be low in 3 years time (7.1%).
Next Steps
Past Performance
How has MicroPort Scientific performed over the past 5 years?
23.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 853 is currently unprofitable.
Growing Profit Margin: 853 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 853 is unprofitable, but has reduced losses over the past 5 years at a rate of 23.3% per year.
Accelerating Growth: Unable to compare 853's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 853 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.7%).
Return on Equity
High ROE: 853 has a negative Return on Equity (-12.93%), as it is currently unprofitable.
Next Steps
Financial Health
How is MicroPort Scientific's financial position?
Financial Position Analysis
Short Term Liabilities: 853's short term assets ($928.2M) exceed its short term liabilities ($348.3M).
Long Term Liabilities: 853's short term assets ($928.2M) exceed its long term liabilities ($673.2M).
Debt to Equity History and Analysis
Debt Level: 853's debt to equity ratio (46.1%) is considered high.
Reducing Debt: 853's debt to equity ratio has reduced from 91.9% to 46.1% over the past 5 years.
Debt Coverage: 853's debt is not well covered by operating cash flow (6.6%).
Interest Coverage: Insufficient data to determine if 853's interest payments on its debt are well covered by EBIT.
Balance Sheet
Next Steps
Dividend
What is MicroPort Scientific current dividend yield, its reliability and sustainability?
0.09%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 853's dividend (0.09%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.06%).
High Dividend: 853's dividend (0.09%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.48%).
Stability and Growth of Payments
Stable Dividend: 853 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 853 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 853 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 853's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
7.2yrs
Average management tenure
CEO
Maxwell Chang (57 yo)
8.33yrs
Tenure
US$3,626,000
Compensation
Dr. Zhaohua Chang, also known as Maxwell, serves as the Chief Executive Officer Shanghai MicroPort Medical (Group) Co., Ltd. He serves as the Chairman of MicroPort Scientific Corporation. He serves as Chai...
CEO Compensation Analysis
Compensation vs Market: Maxwell's total compensation ($USD3.63M) is above average for companies of similar size in the Hong Kong market ($USD764.23K).
Compensation vs Earnings: Maxwell's compensation has increased whilst the company is unprofitable.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.33yrs | US$3.63m | no data | |
| Chief Financial Officer | 10.5yrs | US$426.74k | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Chief Technology Officer | no data | US$311.71k | no data | |
| Chief Human Resources Officer | 6.08yrs | no data | no data | |
| Chief International Business Officer | no data | no data | no data | |
| President of MP Shanghai | no data | US$412.46k | no data | |
| Board Secretary & VP of Corporate General Affairs | no data | no data | no data | |
| Company Secretary | 1yr | no data | no data | |
| Senior Vice President of Supply Chain of Mp Shanghai | no data | no data | no data |
7.2yrs
Average Tenure
55yo
Average Age
Experienced Management: 853's management team is seasoned and experienced (7.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8.33yrs | US$3.63m | no data | |
| Non-Executive Director | 14.17yrs | no data | no data | |
| Independent Non-Executive Director | 10.33yrs | US$12.00k | no data | |
| Independent Non-Executive Director | 10.33yrs | US$38.00k | no data | |
| Independent Non-Executive Director | 4.33yrs | US$38.00k | no data | |
| Non-Executive Director | 2.58yrs | no data | no data | |
| Non-Executive Director | 0.58yr | no data | no data |
7.3yrs
Average Tenure
56yo
Average Age
Experienced Board: 853's board of directors are considered experienced (7.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.4%.
Top Shareholders
Company Information
MicroPort Scientific Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: MicroPort Scientific Corporation
- Ticker: 853
- Exchange: SEHK
- Founded: 1998
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$104.449b
- Shares outstanding: 1.78b
- Website: https://www.microport.com
Number of Employees
Location
- MicroPort Scientific Corporation
- 1601 Zhangdong Road
- Zhangjiang Hi-Tech Park
- Shanghai
- 201203
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 853 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Sep 2010 |
| MSK | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Sep 2010 |
| MCRP.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Sep 2010 |
| 853 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | Yes | Ordinary Shares | HK | HKD | Sep 2010 |
| 853 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | Yes | Ordinary Shares | HK | HKD | Sep 2010 |
Biography
MicroPort Scientific Corporation, an investment holding company, manufactures and markets medical devices in the People’s Republic of China, North America, Europe, other Asian countries, South America, and...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/23 10:14 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.